Quick Answer: Most semaglutide side effects, particularly gastrointestinal symptoms like nausea, typically peak within 48 weeks and gradually improve over 23 months as tolerance develops
10mg vial GLP-1 receptor agonist for metabolic research
For broader affordability context, see Retatrutide Cost Considerations
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: A randomised, controlled, double-blind, ascending dose and phase 2a study
Nausea, vomiting, and diarrhea are the most common side effects after taking these drugs, but in many patients, adjusting the dosage and gradually bringing patients up to a higher weekly dose can ease symptoms, says Brian Downey, director of General Cardiology Services at Tufts Medical Center and assistant professor at Tufts School of Medicine